Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06009588

Comparison of Self- and Balloon-expandable Valves in Patients With Ascending Aortic Dilation Undergoing Transcatheter Aortic Valve Replacement: The AAD-CHOICE

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
China National Center for Cardiovascular Diseases · Other Government
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

This study aimed at comparing the performance of self-expandable valves versus balloon-expandable valves in patients with ascending aortic dilation undergoing transcatheter aortic valve replacement.

Detailed description

Ascending aortic (AA) dilation is a common feature in patients with aortic stenosis (AS), especially in those with bicuspid aortic valve (BAV). For patients undergoing surgical aortic valve replacement (SAVR), current guidelines recommend concomitant aortic repair or replacement if the diameter of AA exceeds 45mm to avoid aortic dissection or rupture. Transcatheter aortic valve replacement (TAVR) has profoundly changed the clinical management of AS patients who cannot tolerate SAVR. For patients who are candidates for TAVR, simultaneous repair of a dilated AA can be technically difficult. The safety and feasibility of the procedure and the fate of AA after the procedure in these patients remain unclear. Moreover, there are limited data comparing the performance of self-expandable valves versus balloon-expandable valves in these patients. The aim of the present study is to evaluate the impact of type of transcatheter heart valves on intra-procedural device success and post-procedural AA progression in patients with dilated AA (≥45mm) undergoing TAVR.

Conditions

Interventions

TypeNameDescription
DEVICEself-expandable valvespatients undergoing TAVR use self-expandable valves
DEVICEballoon-expandable valvespatients undergoing TAVR use balloon-expandable valves

Timeline

Start date
2023-08-31
Primary completion
2026-08-30
Completion
2026-08-30
First posted
2023-08-24
Last updated
2024-08-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06009588. Inclusion in this directory is not an endorsement.